What is PTC Therapeutics's cash ratio?

PTC Therapeutics (PTCT) reported cash ratio of 0.9× in Q1 2026.

How has PTC Therapeutics's cash ratio changed year-over-year?

PTC Therapeutics's cash ratio decreased by 63.7% year-over-year, from 2.5× to 0.9×.

What is the long-term trend for PTC Therapeutics's cash ratio?

Over 5 years (2020 to 2025), PTC Therapeutics's cash ratio has grown at a 6.2% compound annual growth rate (CAGR), from 0.8× to 1×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

PTC Therapeutics PTCT Cash ratio

Cash ratio at other companies

BioMarin PharmaceuticalsBMRN

3.9×+2.2×

ALN

Alnylam PharmaceuticalsALNY

1.3×+0.3×

BridgeBio PharmaBBIO

1.1×-2.5×

Arrowhead ResearchARWR

0.6×-0.2×

United TherapeuticsUTHR

2.1×-0.5×

BiogenBIIB

1.1×+0.6×

Other financials

Income statement

See full

Revenue$272.6M-76.8%

Operating income$45.0M-95.4%

Net income-$2.8M-100%

EPS (diluted)-$0.03-100%

Balance sheet

See full

Cash & equivalents$834.0M-43.7%

Total debt$395.1M+0.1%

Total equity-$180.5M+2.9%

Total assets$2.9B+8.0%

Cash flow

See full

Operating cash flow-$59.0M-107%

CapEx$1.2M-30.6%

Free cash flow-$60.2M-107%

Valuation

See full

Market cap$6.55B+40.3%

Enterprise value$6.11B+77.3%

P/E8×—

P/S7.9×+5.3×

Profitability

See full

Gross margin96%—

Operating margin1.6%-38.7pp

Net margin42.3%+27.4pp

FCF margin39.1%+32.8pp

Returns & leverage

See full

Return on equity-216.7%—

Debt / equity372.3×—

Current ratio2.4×-1.5×

Where this comes from

Calculated from PTC Therapeutics’s reported figures.

cash and equivalents/total current liabilities=0.9×

Based on the most recent quarter.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTC Therapeutics's cash ratio?: PTC Therapeutics (PTCT) reported cash ratio of 0.9× in Q1 2026.
How has PTC Therapeutics's cash ratio changed year-over-year?: PTC Therapeutics's cash ratio decreased by 63.7% year-over-year, from 2.5× to 0.9×.
What is the long-term trend for PTC Therapeutics's cash ratio?: Over 5 years (2020 to 2025), PTC Therapeutics's cash ratio has grown at a 6.2% compound annual growth rate (CAGR), from 0.8× to 1×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.